Inhibition of human immunodeficiency virus type 1 activity in vitro by a new self-stabilized oligonucleotide with guanosine-thymidine quadruplex motifs

Journal of Virology

Volumn 76, Issue 6, 2002, Pages 3015-3022

  Suzuki, Jun Ichiro ^a   Miyano Kurosaki, Naoko ^a   Kuwasaki, Tomoyuki ^a   Takeuchi, Hiroaki ^a   Kawai, Gota ^a   Takaku, Hiroshi ^a  

^a CHIBA INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE DERIVATIVE; OLIGONUCLEOTIDE; THYMIDINE DERIVATIVE;

ABSORPTION SPECTROSCOPY; ARTICLE; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MONONUCLEAR CELL; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; VIRUS GENOME; VIRUS INHIBITION;

GIANT CELLS; GUANOSINE; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; OLIGONUCLEOTIDES; PHOSPHATES; THYMIDINE;

EID: 0036184802     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.6.3015-3022.2002     Document Type: Article

References (46)

1. Protection of hu-PBL-SCID/beige mice from HIV-1 infection by a 6-mer modified oligonucleotide, R-95288
2. Fluorescent dyes specific for quadruplex DNA
3. Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro
4. Mechanism of the inhibition of reverse transcription by antisense oligonucleotides
5. Intramolecular G-quartet motifs confer nuclease resistance to a potent anti-HIV oligonucleotide
6. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain
7. Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS 5320)
8. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
9. An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1
10. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression
11. Identification of a major coreceptor for primary isolates of HIV-1
12. + cells is mediated by the chemokine receptor CC-CKR-5
13. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
14. Short terminally phosphorylated oligoriboguanylic acids effectively inhibit cytopathicity caused by human immunodeficiency virus
15. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1
16. Structure-activity of tetrad-forming oligonucleotides as a potent anti-HIV therapeutic drug
17. Stability-activity relationships of a family of G-tetrad forming oligonucleotides as potent HIV inhibitors. A basis for anti-HIV drug design
18. Developing G-quartet oligonucleotides as novel anti-HIV agents: Focus on anti-HIV drug design
19. 2
20. Hairpin antisense oligonucleotides containing 2′-methoxynucleosides with base-pairing in the stem region at the 3′-end: Penetration, localization, and anti-HIV activity
21. Polydeoxyguanine motifs in a 12-mer phosphorothioate oligodeoxynucleotide augments binding to the v3 loop of HIV-1 gp120 and potency of HIV-1 inhibition independency of G-tetrad formation
22. Antisense strategies to inhibit restenosis
23. Stepwise mechanism of HIV reverse transcriptase: Primer function of phosphorothioate oligodeoxynucleotide
24. Inhibitors of replication and cytopathic effects of human immunodeficiency virus
25. Template. Phosphorothioate oligonucleotide duplexes as inhibitors of HIV-1 reverse transcriptase
26. Increased efficacy of antileishmanial antisense phosphorothioate oligonucleotides in Leishmania amazonensis overexpressing ribonuclease H
27. Inhibition of human immunodeficiency virus type 1 activity in vitro by oligonucleotides composed entirely of guanosine and thymidine
28. Suppression of human immunodeficiency virus type 1 activity in vitro by oligonucleotides which form intramolecular tetrads
29. Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection
30. + cells cocultured with T cells persistently infected with human immunodeficiency virus as demonstrated by flow cytometry
31. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population
32. Pharmacokinetics and tolerability of intravenous trecovirsen (GEM 91), an antisense phosphorothioate oligonucleotide, in HIV-positive subjects
33. Modified deoxyoligonucleotides stable to exonuclease degradation in serum
34. Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene
35. Primary, syncytium-inducing human immunodeficiency virus, type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry
36. Phosphorothioate oligodeoxycytidine interferes with binding of HIV-1 gp120 to CD4
37. Phosphorothioate oligodeoxynucleotides bind to the third variable loop domain (v3) of human immunodeficiency virus type 1 gp120
38. Inhibition of human immunodeficiency virus type 1 infection in SCID-hu Thy/Liv mice by the G-quartet-forming oligonucleotide, ISIS 5320
39. 2 quadruplex: Evidence for sequential syn-syn deoxyguanosines
40. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: Frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex
41. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: Studies on sequential HIV isolates
42. Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality
43. Human immunodeficiency virus (HIV)-induced cell fusion: Quantification and its application for the simple and rapid screening of anti-HIV substances in vitro
44. Synergistic inhibition of HIV-1 by an antisense oligonucleotide and nucleoside analog reverse transcriptase inhibitors
45. Oligodeoxynucleotide stability in subcellular extracts and culture media
46. Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion